
متى سيتم صرف الادوية بهذه الطريقة ؟؟؟ وهل تعتقدون ان هذه الطريقة ستنجح لدينا في الدول العربية ؟؟؟ ثم ما هو مصير الصيدلاني ؟؟؟…
مؤسسات صيدلانية
مستودعات ومصانع الادوية
EMA committee grants positive opinion for GlaxoSmithKline, Valeant's Trobalt
GlaxoSmithKline and Valeant Pharmaceuticals announced that the European Medicines Agency's Committee for Medicinal Products for
Human Use issued a positive opinion recommending marketing approval of Trobalt (retigabine) as an adjunctive treatment for partial onset seizures in adults with epilepsy.
The drug, which is known as ezogabine in the US, is being jointly developed by the two companies. In December, Trobalt received a preliminary approval from Swissmedic.

|
Joomlastyle.net web hosting & design services |